Verwiel Frank - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 17, 2024, Verwiel Frank's relationship to Intellia Therapeutics, Inc. (NTLA) is Director, and currently has 17,948 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NTLA insiders.

Data Source: SEC.
Verwiel Frank - Insider Non-Derivative Transactions of NTLA Common Stock
Verwiel Frank - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 18, 2024 Sell -- (Common Stock) 1505 25 17948
Jun 13, 2024 Acquisition -- (Common Stock) 7737 0 19453
Jun 15, 2023 Acquisition -- (Common Stock) 4425 0 11716